We have been covering the economy, bringing you live coverage from beijing. In the meantime, this is what is happening in europe. Euro area november services pmi falling to 51. 5. Anything above 50 is expansionary but below forecasts. Again, this is for yourarea manufacturing for the month of november. Quite a lot going on in the markets. It is all about the ecb speech and Christine Lagarde. How she means new policies will be taking place. Stocks overall on the up. We had a similar rally when it came to asia. Pointing towards a marginally strong open in the u. S. As investors try to figure out headlines on the trade dispute. Say, a lot of the talk in beijing was on that. The dollar is mostly steady. Lets get first word news in newark city. New york city. I fear this was all going to blow up. Those were the exact words spoken by fiona hill in the impeachment hearings, that is what she told fellow diplomats but that she now understands why he was not involved in security or Foreign Polic
Share this article
Share this article
SAN MATEO, Calif., July 28, 2021 /PRNewswire/ Rakuten Medical, Inc., a global clinical stage biotechnology company focused on developing and commercializing innovative oncology products for multiple indications, today announced the completion of a $166 million Series D preferred stock financing, including $75 million in new capital and the conversion of $91 million of convertible promissory notes, including accrued interest. The round was led by General Catalyst with additional participation from existing investors, including Rakuten Group and SBI Group.
Rakuten Medical s lead drug, ASP-1929, achieved approval in Japan for unresectable locally advanced or locally recurrent head and neck cancer in September 2020. The company is continuing to develop additional therapies on its Illuminox™ platform for a range of oncological indications.
4 weeks ago
The 800-Page Report on Cybersecurity Trends, Strategic Activity, and Industry Predictions Spotlights the Impact of Accelerating Digital Transformation and Resulting Cybersecurity Tailwinds That Are Expected to Last Well Past 2021
SAN FRANCISCO–(BUSINESS WIRE)–Momentum Cyber, the premier trusted advisor to the Cybersecurity industry, today released its fourth annual Cybersecurity Almanac for 2021 – the most comprehensive and accurate strategic data and insights available on the industry. Culled from analysis of over
3,500 Cybersecurity companies across the globe and strategic deal activity including IPOs, mergers and acquisitions (M&A), venture capital and private equity financings, and the market impact of news and events, the Cybersecurity Almanac chronicles the key trends which made 2020 a unique and strong year for the industry including